Statutes
Statutes - The statutes governing the Maryland Prescription Drug Affordability Board are located at Md. Code Annotated, Health-General Article §§ 21-2C-01 – 16. The Maryland General Assembly provides an online catalog of the Maryland Code here: https://mgaleg.maryland.gov/mgawebsite/laws/statutes
Regulations
NOTICE:
COMAR 14.01.04 Cost Review Study Process
Emergency Action
The Prescription Drug Affordability Board seeks emergency action on proposed amendments to .05 under COMAR 14.01.04 Cost Review Study Process. The text of the proposed amendments is available here.
PROPOSED ACTION:
COMAR 14.01.04 Cost Review Study Process
The Maryland Prescription Drug Affordability Board proposes to amend Regulation .05 under COMAR 14.01.04 Cost Review Study Process. The text of the proposed amendments are available in the November 1, 2024 version of the Maryland register located
here.
Comments may be submitted to Christina Shaklee, Health Policy Analyst Advanced, by:
Mail
Maryland Prescription Drug Affordability Board
16900 Science Drive, Suite 112-114
Bowie, MD 20715;
Phone 410-703-7015.
Comments will be accepted through December 2, 2024.
ARCHIVED ACTIONS:
Draft Proposed Regulations for Comment (Posted: 10/28/2024)
The PDAB solicited comments informing the development of draft regulations. Comments were due by November 8, 2024 on the draft regulations listed below.
COMAR 14.01.02 Prescription Drug Affordability Fund
The Maryland Prescription Drug Affordability Board proposes to amend Regulations .02 under COMAR 14.01.02 Prescription Drug Affordability Fund. The text of the proposed amendments are available in the May 31, 2024 version of the Maryland register located here.
Comments were accepted through July 1, 2024.
COMAR 14.01.04 Cost Review Study Process
The Prescription Drug Affordability Board proposes to adopt a new chapter of regulations 14.01.04 Cost Review Study Process.
Notice of this proposed action was published in the Maryland Register on September 22, 2023. The text of
the proposed amendments is available.
Comments were accepted through October 23, 2023.
COMAR 14.01.01 General Provisions
The Prescription Drug Affordability Board proposes to amend Regulation .01 and adopt new Regulations .02—.05 under COMAR 14.01.01 General Provisions.
Notice of this proposed action was published in the Maryland Register on September 22, 2023. The text of
the proposed amendments is available.
Comments were accepted through October 23, 2023.
